File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion

TitleThe postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion
Authors
Issue Date1998
PublisherWiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1354-523X&site=1
Citation
Oral Diseases, 1998, v. 4 n. 4, p. 260-267 How to Cite?
AbstractOBJECTIVE: Postantifungal effect (PAFE) is defined as the suppression of growth that persists following limited exposure of yeasts to antimycotics and subsequent removal of the drug. As there are no data on the PAFE of oral C. albicans isolates the main aim of this investigation was to measure the PAFE of 10 oral isolates of C. albicans following limited exposure (1 h) to five antifungal drugs, including nystatin which has not been previously used in PAFE assays. A secondary aim of the study was to evaluate the biological significance of PAFE, using a nystatin pre-exposed isolate of C. albicans and observing its adherence to denture acrylic surfaces, during the PAFE period. DESIGN: A total of 10 oral isolates of C. albicans were examined for the presence of the PAFE after 1 h exposure to five antifungal drugs, nystatin, amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole. PAFE was automatically assessed with the help of a Spectramax machine which utilizes the principle of periodic turbidometric assessment of growth rates at a given temperature over a given period. The data thus collected are automatically processed in a graphic format as a computer printout. The PAFE was determined as the difference in time (h) required for growth of the drug-free control and the drug-exposed test cultures to increase to 0.05 absorbance level following removal of the antifungal agent (by repeated washing). The adhesion of the single isolate to denture acrylic following limited exposure to nystatin was assessed by a previously described in vitro adhesion assay. RESULTS: Significant PAFE were observed for nystatin, amphotericin-B and 5- fluorocytosine. A marginal PAFE was observed for ketoconazole and little or none for fluconazole. The mean duration of the PAFE of nystatin, amphotericin-B, 5-fluorocytosine, ketoconazole and fluconazole were 2.89 (±0.27) h, 2.83 (±0.23)h, 3.18 (±0.31) h, 0.65 (±0.11) h and 0.16 (±0.06) h, respectively. The mean percentage reduction of adhesion of oral C. albicans BU47204 to denture acrylic during the PAFE period following exposure to nystatin for 10, 30, 50, 70 and 90 min was 9.12%, 61.73%, 65.99%, 82.16% and 83.14%, respectively. CONCLUSIONS: These in vitro findings imply that even a short period of exposure to antifungals may result in modulation of the growth and the virulent attributes of C. albicans, which however is largely dictated by the antimycotic agent in question. Whether such mechanisms operate in vivo needs to be clarified by further studies.
Persistent Identifierhttp://hdl.handle.net/10722/154050
ISSN
2015 Impact Factor: 2.0
2015 SCImago Journal Rankings: 0.828
References

 

DC FieldValueLanguage
dc.contributor.authorEllepola, Aen_US
dc.contributor.authorSamaranayake, LPen_US
dc.date.accessioned2012-08-08T08:23:00Z-
dc.date.available2012-08-08T08:23:00Z-
dc.date.issued1998en_US
dc.identifier.citationOral Diseases, 1998, v. 4 n. 4, p. 260-267en_US
dc.identifier.issn1354-523Xen_US
dc.identifier.urihttp://hdl.handle.net/10722/154050-
dc.description.abstractOBJECTIVE: Postantifungal effect (PAFE) is defined as the suppression of growth that persists following limited exposure of yeasts to antimycotics and subsequent removal of the drug. As there are no data on the PAFE of oral C. albicans isolates the main aim of this investigation was to measure the PAFE of 10 oral isolates of C. albicans following limited exposure (1 h) to five antifungal drugs, including nystatin which has not been previously used in PAFE assays. A secondary aim of the study was to evaluate the biological significance of PAFE, using a nystatin pre-exposed isolate of C. albicans and observing its adherence to denture acrylic surfaces, during the PAFE period. DESIGN: A total of 10 oral isolates of C. albicans were examined for the presence of the PAFE after 1 h exposure to five antifungal drugs, nystatin, amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole. PAFE was automatically assessed with the help of a Spectramax machine which utilizes the principle of periodic turbidometric assessment of growth rates at a given temperature over a given period. The data thus collected are automatically processed in a graphic format as a computer printout. The PAFE was determined as the difference in time (h) required for growth of the drug-free control and the drug-exposed test cultures to increase to 0.05 absorbance level following removal of the antifungal agent (by repeated washing). The adhesion of the single isolate to denture acrylic following limited exposure to nystatin was assessed by a previously described in vitro adhesion assay. RESULTS: Significant PAFE were observed for nystatin, amphotericin-B and 5- fluorocytosine. A marginal PAFE was observed for ketoconazole and little or none for fluconazole. The mean duration of the PAFE of nystatin, amphotericin-B, 5-fluorocytosine, ketoconazole and fluconazole were 2.89 (±0.27) h, 2.83 (±0.23)h, 3.18 (±0.31) h, 0.65 (±0.11) h and 0.16 (±0.06) h, respectively. The mean percentage reduction of adhesion of oral C. albicans BU47204 to denture acrylic during the PAFE period following exposure to nystatin for 10, 30, 50, 70 and 90 min was 9.12%, 61.73%, 65.99%, 82.16% and 83.14%, respectively. CONCLUSIONS: These in vitro findings imply that even a short period of exposure to antifungals may result in modulation of the growth and the virulent attributes of C. albicans, which however is largely dictated by the antimycotic agent in question. Whether such mechanisms operate in vivo needs to be clarified by further studies.en_US
dc.languageengen_US
dc.publisherWiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=1354-523X&site=1en_US
dc.relation.ispartofOral Diseasesen_US
dc.subject.meshAcrylic Resinsen_US
dc.subject.meshAmphotericin B - Pharmacologyen_US
dc.subject.meshAnalysis Of Varianceen_US
dc.subject.meshAntifungal Agents - Pharmacologyen_US
dc.subject.meshCandida Albicans - Drug Effects - Growth & Developmenten_US
dc.subject.meshCell Adhesion - Drug Effectsen_US
dc.subject.meshDenture Bases - Microbiologyen_US
dc.subject.meshFluconazole - Pharmacologyen_US
dc.subject.meshFlucytosine - Pharmacologyen_US
dc.subject.meshKetoconazole - Pharmacologyen_US
dc.subject.meshMicrobial Sensitivity Testsen_US
dc.subject.meshNystatin - Pharmacologyen_US
dc.titleThe postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesionen_US
dc.typeArticleen_US
dc.identifier.emailSamaranayake, LP:lakshman@hku.hken_US
dc.identifier.authoritySamaranayake, LP=rp00023en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid10200705-
dc.identifier.scopuseid_2-s2.0-0032422584en_US
dc.identifier.hkuros38956-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0032422584&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume4en_US
dc.identifier.issue4en_US
dc.identifier.spage260en_US
dc.identifier.epage267en_US
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridEllepola, A=6604060863en_US
dc.identifier.scopusauthoridSamaranayake, LP=7102761002en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats